In the premiere episode of Behind the Breakthroughs, Geoff Oxnard, MD, VP of Clinical Development at Lilly and a Thoracic Oncologist at Boston Medical Center, shares his journey in precision medicine, beginning with his introduction to genetic testing as a Medical Oncology Fellow at Memorial Sloan-Kettering Cancer Center and as an academic researcher.
Dr. Oxnard discusses how differences in impact and reach influenced his decision to move from academia to industry. He also explains how the adoption of precision testing in the United States is influenced by perspective rather than accessibility. This episode also covers flexible enrollment in clinical trials, adapting to patient perspectives on clinical research as care, the current state of precision medicine, particularly precision oncology, in the United States and elsewhere, and more.
Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.
Produced by Bill Levine
Hosted by Jonathan D. Grinstein, PhD
Music provided by Artem Hramushkin
Audio mixed and mastered by Jason Mack
Hosted on Acast. See acast.com/privacy for more information.